Abdulla, 2007, Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor, PLoS Med., 4, 10.1371/journal.pmed.0040014
Abdulla, 2009, Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening, PLoS Neglected Trop. Dis., 3, e478, 10.1371/journal.pntd.0000478
Andrews, 1985, Praziquantel: mechanisms of anti-schistosomal activity, Pharmacol. Ther., 29, 129, 10.1016/0163-7258(85)90020-8
Andrews, 1983, Praziquantel, Med Res Rev, 3, 147, 10.1002/med.2610030204
Basch, 1981, Cultivation of Schistosoma mansoni in vitro. I. Establishment of cultures from cercariae and development until pairing, J. Parasitol., 67, 179, 10.2307/3280632
Bisel, 2008, The tert-butyl group in chemistry and biology, Org. Biomol. Chem., 6, 2655, 10.1039/b800083b
Blau, 1985, Plasticity of the differentiated state, Science, 230, 758, 10.1126/science.2414846
Bojarova, 2008, Sulfotransferases, sulfatases and formylglycine-generating enzymes: a sulfation fascination, Curr. Opin. Chem. Biol., 12, 573, 10.1016/j.cbpa.2008.06.018
Botros, 2005, Effect of praziquantel on the immature stages of Schistosoma haematobium, Int. J. Parasitol., 35, 1453, 10.1016/j.ijpara.2005.05.002
Brindley, 1987, The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response, J. Immunol., 139, 215, 10.4049/jimmunol.139.1.215
Bueding, 1982, The antischistosomal activity of oltipraz, Res. Commun. Chem. Pathol. Pharmacol., 37, 293
Caffrey, 2007, Chemotherapy of schistosomiasis: present and future, Curr. Opin. Chem. Biol., 11, 433, 10.1016/j.cbpa.2007.05.031
Caffrey, 2015, Schistosomiasis and its treatment, Future Med. Chem., 7, 675, 10.4155/fmc.15.27
Carey, 2006, Analysis of the reactions used for the preparation of drug candidate molecules, Org. Biomol. Chem., 4, 2337, 10.1039/b602413k
Challener, 2001
Colley, 2014, Human schistosomiasis, Lancet, 383, 2253, 10.1016/S0140-6736(13)61949-2
Colley, 1974, Schistosoma mansoni: simplified method for the production of schistosomules, Exp. Parasitol., 35, 44, 10.1016/0014-4894(74)90005-8
Coughtrie, 1998, Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases, Chem. Biol. Interact., 109, 3, 10.1016/S0009-2797(97)00117-8
Cruciani, 2013, Exposition and reactivity optimization to predict sites of metabolism in chemicals, Drug Discov. Today Technol., 10, e155, 10.1016/j.ddtec.2012.11.001
Cruciani, 2000, Molecular fields in quantitative structure–permeation relationships: the VolSurf approach, J. Mol. Struct.: Theochem, 503, 17, 10.1016/S0166-1280(99)00360-7
Cruciani, 2000, VolSurf: a new tool for the pharmacokinetic optimization of lead compounds, Eur. J. Pharmaceut. Sci.: Official J. Eur. Fed. Pharmaceut. Sci., 11, S29, 10.1016/S0928-0987(00)00162-7
Davies, 1993, Physiological parameters in laboratory animals and humans, Pharm. Res. (N. Y.), 10, 1093, 10.1023/A:1018943613122
de Oliveira Penido, 2008, Antischistosomal activity of aminoalkanethiols, aminoalkanethiosulfuric acids and the corresponding disulfides, Acta Trop., 108, 249, 10.1016/j.actatropica.2008.10.005
Doenhoff, 1987, Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice, Trans. R. Soc. Trop. Med. Hyg., 81, 947, 10.1016/0035-9203(87)90360-9
Dufrasne, 2011, Quinone methides and their prodrugs: a subtle equilibrium between cancer promotion, prevention, and cure, Curr. Med. Chem., 18, 3995, 10.2174/092986711796957301
Duvall, 1967, An improved perfusion technique for recovering adult schistosomes from laboratory animals, Am. J. Trop. Med. Hyg., 16, 483, 10.4269/ajtmh.1967.16.483
Engel, 1985, Trypanosoma cruzi: biological characterization of clones derived from chronic chagasic patients. II. Quantitative analysis of the intracellular cycle, J. Protozool., 32, 80, 10.1111/j.1550-7408.1985.tb03017.x
Glaser, 2015, Anti-schistosomal activity of cinnamic acid esters: eugenyl and thymyl cinnamate induce cytoplasmic vacuoles and death in schistosomula of Schistosoma mansoni, Molecules, 20, 10873, 10.3390/molecules200610873
Gőnnert, 1977, Praziquantel, a new board-spectrum antischistosomal agent, Z. Parasitenkd., 52, 129, 10.1007/BF00389899
Hotez, 2018, Human parasitology and parasitic diseases: heading towards 2050, Adv. Parasitol., 100, 29, 10.1016/bs.apar.2018.03.002
Hotez, 2008, Helminth infections: the great neglected tropical diseases, J. Clin. Invest., 118, 1311, 10.1172/JCI34261
http://unitingtocombatntds.org/wp-content/themes/tetloose/app/staticPages/fifthReport/files/fifth_progress_report_english.pdf, 2014.
Imai, 1981, Acute toxicological studies of captopril in rats and mice, J. Toxicol. Sci., 6, 179, 10.2131/jts.6.SupplementII_179
Jacobsen, 2000, In vitro evaluation of the disposition of a novel cysteine protease inhibitor, Drug Metab. Dispos., 28, 1343
Jaffe, 1986, Adverse effects profile of sulfhydryl compounds in man, Am. J. Med., 80, 471, 10.1016/0002-9343(86)90722-9
Kalgutkar, 2005, A comprehensive listing of bioactivation pathways of organic functional groups, Curr. Drug Metabol., 6, 161, 10.2174/1389200054021799
Keiser, 2009, Mefloquine-an aminoalcohol with promising antischistosomal properties in mice, PLoS Neglected Trop. Dis., 3, 10.1371/journal.pntd.0000350
Kim, 2017, Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease, Aliment Pharmacol. Ther., 45, 1073, 10.1111/apt.13981
King, 2010, Parasites and poverty: the case of schistosomiasis, Acta Trop., 113, 95, 10.1016/j.actatropica.2009.11.012
Klayman, 1964, The synthesis of N-substituted 2-aminoethanethiosulfuric acids, J. Med. Chem., 7, 823, 10.1021/jm00336a041
Klayman, 1969, Potential antiradiation agents. I. Primary aminoalkanethiosulfuric acids, J. Med. Chem., 12, 510, 10.1021/jm00303a600
Klayman, 1969, Potential antiradiation agents. II. Guanidinoalkanethiosulfuric acids, J. Med. Chem., 12, 723, 10.1021/jm00304a053
Kraemer, 1986, The effect of dexamethasone on transferrin secretion by cultured fetal rat hepatocytes, Eur. J. Cell Biol., 42, 52
Lau, 2002, Development of a novel in vitro model to predict hepatic clearance using fresh, cryopreserved, and sandwich-cultured hepatocytes, Drug Metab. Dispos., 30, 1446, 10.1124/dmd.30.12.1446
Lipinski, 2001, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev., 46, 3, 10.1016/S0169-409X(00)00129-0
Long, 2016, Structure-bioactivity relationship for benzimidazole thiophene inhibitors of polo-like kinase 1 (PLK1), a potential drug target in Schistosoma mansoni, PLoS Neglected Trop. Dis., 10, 10.1371/journal.pntd.0004356
Long, 2017, Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target, PLoS Neglected Trop. Dis., 11, 10.1371/journal.pntd.0005680
Marcellino, 2012, WormAssay: a novel computer application for whole-plate motion-based screening of macroscopic parasites, PLoS Neglected Trop. Dis., 6, 10.1371/journal.pntd.0001494
Mkoji, 1990, Effect of oltipraz on the susceptibility of adult Schistosoma mansoni to killing by mouse peritoneal exudate cells, Parasitol. Res., 76, 435, 10.1007/BF00933553
Monks, 2002, The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers, Curr. Drug Metabol., 3, 425, 10.2174/1389200023337388
Moreira, 2007, A study of the activity of 2-(alkylamino)-1-phenyl-1-ethanethiosulfuric acids against infection by Schistosoma mansoni in a murine model, Trans. R. Soc. Trop. Med. Hyg., 101, 385, 10.1016/j.trstmh.2006.06.006
Moreira, 2000, Synthesis of 2-(alykylamino)-1-phenylethane-1-thiosulfuric acids, potential schistosomicides Quimica Nova, 23, 447, 10.1590/S0100-40422000000400003
Nakabayashi, 1984, Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium, Gann, 75, 151
Nelson, 1976, Experimental chemotherapy of schistosomiasis XII. Active derivatives of aminoethanethiosulfuric acids, Rev. Inst. Med. Trop. Sao Paulo, 18, 365
Nelson, 1989, Synthesis of potential schistosomicides: 2-(N-alkylamino)-1-alkanethiosulfuric acids and related thiols and disulfides, 25
Nwaka, 2006, Innovative lead discovery strategies for tropical diseases, Nat. Rev. Drug Discov., 5, 941, 10.1038/nrd2144
Pellegrino, 1956, A perfusion technic for recovery of Schistosoma mansoni from experimentally infected Guinea pigs, Rev. Bras. Malariol. Doencas Trop., 8, 589
Penido, 1999, Efficacy of a new schistosomicidal agent 2-[(methylpropyl)amino]-1-octanethiosulfuric acid against an oxamniquine resistant Schistosoma mansoni isolate, Mem. Inst. Oswaldo Cruz, 94, 811, 10.1590/S0074-02761999000600018
Penido, 1994, Schistosomicidal activity of alkylaminooctanethiosulfuric acids, Mem. Inst. Oswaldo Cruz, 89, 595, 10.1590/S0074-02761994000400017
Penido, 1995, Metabolism by Schistosoma mansoni of a new schistosomicide: 2-[(1-methylpropyl)amino]-1-octanethiosulphuric acid, Parasitology, 111, 177, 10.1017/S0031182000064921
Pica-Mattoccia, 2004, Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment, Int. J. Parasitol., 34, 527, 10.1016/j.ijpara.2003.12.003
Rheinberg, 1998, Schistosoma haematobium, S. intercalatum, S. japonicum, S. mansoni, and S. rodhaini in mice: relationship between patterns of lung migration by schistosomula and perfusion recovery of adult worms, Parasitol. Res., 84, 338, 10.1007/s004360050407
Rojo-Arreola, 2014, Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis, PloS One, 9, 10.1371/journal.pone.0087594
Rowland, 2013, The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification, Int. J. Biochem. Cell Biol., 45, 1121, 10.1016/j.biocel.2013.02.019
Sabah, 1986, Schistosoma mansoni: chemotherapy of infections of different ages, Exp. Parasitol., 61, 294, 10.1016/0014-4894(86)90184-0
Sassine, 2008, An electrospray ionization tandem mass spectrometric study of p-tert-butylcalix[6]arene complexation with ammonium hydroxide, and ammonium and sodium ions, Rapid Commun. Mass Spectrom.: RCM (Rapid Commun. Mass Spectrom.), 22, 385, 10.1002/rcm.3352
Smith, 2008, Determination of microsome and hepatocyte scaling factors for in vitro/in vivo extrapolation in the rat and dog, Xenobiotica, 38, 1386, 10.1080/00498250802491662
Sohlenius-Sternbeck, 2006, Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements, Toxicol. Vitro, 20, 1582, 10.1016/j.tiv.2006.06.003
Štefanić, 2010, RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening, PLoS Neglected Trop. Dis., 4, 10.1371/journal.pntd.0000850
Utzinger, 2011, From innovation to application: social-ecological context, diagnostics, drugs and integrated control of schistosomiasis, Acta Trop., 120, 10.1016/j.actatropica.2010.08.020
Veber, 2002, Molecular properties that influence the oral bioavailability of drug candidates, J. Med. Chem., 45, 2615, 10.1021/jm020017n
Venturello, 1983, A new, effective catalytic system for epoxidation of olefins by hydrogen peroxide under phase-transfer conditions, J. Org. Chem., 48, 3831, 10.1021/jo00169a052
Wang, 2005, Quinone methide derivatives: important intermediates to DNA alkylating and DNA cross-linking actions, Curr. Med. Chem., 12, 2893, 10.2174/092986705774454724
Weeks, 2018, Sertraline, paroxetine, and chlorpromazine are rapidly acting anthelmintic drugs capable of clinical repurposing, Sci. Rep., 8, 975, 10.1038/s41598-017-18457-w
Williams, 2013, Thioredoxin glutathione reductase-dependent redox networks in platyhelminth parasites, Antioxidants Redox Signal., 19, 735, 10.1089/ars.2012.4670
Xiao, 1987, Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel, Chin Med J (Engl), 100, 759
Zanger, 2013, Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation, Pharmacol. Ther., 138, 103, 10.1016/j.pharmthera.2012.12.007